PRDX3 expression was associated with platinum resistance in ovarian cancer, and siRNA targeting of PRDX3 triggered cisplatin–induced apoptosis in SKOV3 ovarian cancer cells through suppression of the NF–κB signaling pathway [60,61]. This evidence concerns the gene NFKB1 and ovarian carcinoma.